☆ 4.8 Article

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses

Ming-Ling Chang et al.

Summary: Chronic hepatitis B virus (HBV) infection is a complex process involving interactions among HBV, hepatocytes, and the host immune system. Hepatitis B flares can occur in both HBeAg-positive and HBeAg-negative patients, and the clinical manifestations vary. This review focuses on the management of HBV flares in HBeAg-negative chronic hepatitis B (CHB) patients and provides insight into the immunopathogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Immunology

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection

Shuling Wu et al.

Summary: Functional cure is considered achieved when chronic hepatitis B patients achieve HBsAg seroclearance after treatment. Clearing the virus is challenging due to the difficulty in clearing both cccDNA and integrated dslDNA. High levels of HBsAg in the serum lead to immune system failure, making it unable to produce an effective antiviral response. Only less than 1% of chronic hepatitis B patients are cured annually with antiviral treatment. Coinfection with other viruses such as HIV, HCV, and HDV makes it even more difficult to cure. However, it has been found that patients with coinfection have a higher probability of achieving HBsAg seroclearance, especially those with HBV/HIV coinfection with up to 36% 5-year seroclerance rate. This interesting phenomenon is related to the functional reconstruction of the immune system after antiretroviral therapy (ART).

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Microbiology

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients

Minghui Li et al.

Summary: Intermittent interferon therapy can help improve the rate of HBsAg disappearance in chronic hepatitis B patients. Early HBsAg response significantly affects HBsAg disappearance during retreatment period, with baseline HBsAg and 12-week HBsAg response during retreatment having higher predictive value.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Virology

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients

Minghui Li et al.

Summary: This study assessed the durability of HBsAg clearance achieved by interferon-based therapies in HBeAg-positive CHB patients. The results showed that patients receiving longer consolidation treatment had higher rates of sustained HBsAg negativity and higher anti-HBs levels. However, the occurrence of HBsAg reversion and HBV DNA reversion still existed.

VIROLOGICA SINICA (2022)

Add to Collection

Article Virology

Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a

Minghui Li et al.

Summary: The study showed that HBsAg levels at 12 and 24 weeks could predict HBsAg loss at 96 and 120 weeks in HBeAg-negative CHB patients, with better predictive ability at 24 weeks compared to 12 weeks.

VIROLOGICA SINICA (2021)

Add to Collection

Review Gastroenterology & Hepatology

Chronic hepatitis B: the demise of the 'inactive carrier' phase

Apostolos Koffas et al.

Summary: Chronic hepatitis B remains a global healthcare burden, with reductions in incidence but ongoing challenges with liver cirrhosis and hepatocellular carcinoma. Advances in understanding the immunopathogenesis of CHB have led to changes in clinical categorization, encouraging a lower treatment threshold and a 'Treat All' approach.

HEPATOLOGY INTERNATIONAL (2021)

Add to Collection

Review Virology

HBV-Integration Studies in the Clinic: Role in the Natural History of Infection

Teresa Pollicino et al.

Summary: Hepatitis B virus (HBV) infection is a major global health issue that can cause acute and chronic liver diseases, including cirrhosis and hepatocellular carcinoma. HBV DNA integration into the host genome is essential for viral replication and establishment of chronic infection, and also plays a role in liver tumorigenesis.

VIRUSES-BASEL (2021)

Add to Collection

Review Gastroenterology & Hepatology

Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis

Mingjuan Tan et al.

Summary: Many people with chronic HBV infection worldwide may be eligible for treatment, but the proportion of those who are actually eligible is not high. Future studies should focus more on reporting treatment eligibility in order to improve global treatment coverage.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity

Aleksei Suslov et al.

Summary: HBeAg seroconversion in chronic hepatitis B is associated with a significant decrease in serum HBV DNA levels and reduction of cccDNA content. Transition to HBeAg-negative chronic infection is characterized by strong inhibition of cccDNA transcriptional activity and reduced replication efficiency downstream of pgRNA in some patients.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis

Maurizia R. Brunetto et al.

Summary: The study evaluated the diagnostic value of HBcrAg assay for distinguishing between HBeAg-negative infection (ENI) and chronic hepatitis B (CHB), demonstrating high diagnostic performance in accurately identifying CHB patients independently of HBV genotype.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis

Ryan T. Anderson et al.

Clinical Gastroenterology and Hepatology (2020)

Add to Collection

Article Gastroenterology & Hepatology

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance

Filippo Oliveri et al.

LIVER INTERNATIONAL (2017)

Add to Collection

Article Virology

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA

Michelle Martinot-Peignoux et al.

JOURNAL OF CLINICAL VIROLOGY (2013)

Add to Collection

Review Gastroenterology & Hepatology

Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review

George V. Papatheodoridis et al.

JOURNAL OF HEPATOLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers

Hana Park et al.

LIVER INTERNATIONAL (2012)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

Maurizia Rossana Brunetto et al.

GASTROENTEROLOGY (2010)

Add to Collection

Article Gastroenterology & Hepatology

Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients

Rami Moucari et al.

HEPATOLOGY (2009)

Add to Collection

Review Gastroenterology & Hepatology

HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B

Yun-Fan Liaw

HEPATOLOGY INTERNATIONAL (2009)

Add to Collection

Article Gastroenterology & Hepatology

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT

Manoj Kumar et al.

GASTROENTEROLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Spontaneous relapse of hepatitis in inactive HBsAg carriers

Chia-Ming Chu et al.

HEPATOLOGY INTERNATIONAL (2007)

Add to Collection

Article Gastroenterology & Hepatology

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

YS Hsu et al.

HEPATOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.